Found 26 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

18 years - 75 years
All genders
Phase 2
Interventional
This study investigates the effects of an investigational medication on adults with non-responsive celiac disease, where symptoms persist despite a gluten-free diet. This study aims to evaluate how the investigational medication affects changes in the intestinal lining compared to a placebo, focusing on the villous height to crypt depth ratio, …
18 years - 75 years
All genders
Phase 2
Interventional
This study investigates an investigational medication for adults with moderate to severe Crohn's Disease. The purpose of this study is to evaluate the efficacy and safety of different doses of the investigational medication compared to a placebo. A placebo is an inactive substance that looks like the investigational medicine/vaccine but …
18 years or above
All genders
Phase 3
Interventional
This study investigates the effectiveness and safety of an investigational medication compared to a placebo in adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) whose condition does not respond to available treatments. The study aims to determine if the investigational medication can provide better outcomes for patients who have not responded …
18 years or above
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication on individuals with warm autoimmune hemolytic anemia (wAIHA). The purpose is to compare the investigational medication with a placebo to determine its effectiveness and safety in improving hemoglobin levels in participants aged 18 and older with a confirmed diagnosis of primary …
18 years - 80 years
All genders
Phase 2
Interventional
This study investigates the effectiveness, safety, and tolerability of an investigational medication administered subcutaneously compared to a placebo in adults with high-risk asthma. This study is designed for adults between the ages of 18 and 80 who have asthma but are not eligible for biologic treatments.Participants in the study will …
18 years - 75 years
All genders
Phase 2
Interventional
This study investigates the efficacy and safety of an investigational medication in adults with moderate-to-severe ulcerative colitis (UC). The purpose of this study is to evaluate how different doses of the investigational medication affect clinical remission in participants with moderate-to-severe UC.Participants will undergo procedures including a screening period and a …
18 years or above
All genders
Phase 3
Interventional
This study investigates the effectiveness and safety of an investigational medication compared to intravenous immunoglobulin (IVIg) in adults with chronic inflammatory demyelinating polyneuropathy (CIDP). The study focuses on participants who are currently receiving IVIg but continue to experience physical challenges despite treatment.Participants will be randomly assigned to receive either the …
1 year - 25 years
All genders
Phase 3
Interventional
This study investigates the efficacy and safety of an investigational medication compared to a placebo in participants aged 1 to 25 years with Stage 3 Type 1 diabetes. Participants will be randomly assigned to receive either the investigational medication or a placebo, both administered by intravenous infusion.Participants will undergo various …
18 years or above
All genders
Phase 3
Interventional
This study investigates the efficacy, safety, and tolerability of an investigational medication in adults with chronic rhinosinusitis with nasal polyps (CRSwNP). The study includes participants aged 18 and older who have not had success with standard treatments.Participants will receive either the investigational medication or a placebo, in addition to their …
18 years or above
All genders
Phase 3
Interventional
This study investigates the efficacy, safety, and tolerability of an investigational medication in participants with chronic rhinosinusitis with nasal polyps (CRSwNP). The study aims to compare two dosing regimens of the investigational medication with a placebo, in addition to standard treatment with intranasal corticosteroids.Participants will undergo a series of procedures …
1 - 10 of 26